Advanced Micro Devices, Inc. - Common Stock (AMD)

The GPU giant expects almost $20 billion in CPU sales this year.

What happened? A number of stocks fell in the afternoon session after warnings emerged that ongoing component supply chain bottlenecks and cleanroom space co...

AMD has a lot of growth priced into its stock already.

Arm Holdings could be the biggest winner of the AI-fueled server CPU boom.

This exchange-traded fund invests in some of the world's best artificial intelligence stocks.

4D Molecular Therapeutics (NASDAQ:FDMT) used its first Investor Day to outline its development and commercial plans for 4D-150, an investigational intravitreal gene therapy for wet age-related macular degeneration, or wet AMD. Company executives and retina specialists described the therapy as a pote

These stocks all trade at share prices that could make a split attractive.

REGENXBIO (NASDAQ:RGNX) outlined its clinical, manufacturing and commercialization plans for sura-vec, an investigational one-time subretinal gene therapy for wet age-related macular degeneration, or wet AMD, during a company event featuring retina specialists and executives. The company said it ex

Investing today in Broadcom, Marvell, AMD, and Arm could produce big returns by 2030.

What happened? A number of stocks jumped in the afternoon session after strong demand for artificial intelligence hardware and robust corporate earnings reig...

What happened? A number of stocks jumped in the afternoon session after strong demand for artificial intelligence hardware and robust corporate earnings reig...

What happened? A number of stocks jumped in the afternoon session after strong demand for artificial intelligence hardware and robust corporate earnings reig...

AMD and Nvidia are two major competitors in the AI computing realm.

AMD's latest AI move reaches far beyond today's chips. Here's what the deal could mean for future growth, competitive advantage, dilution, and the risks investors cannot ignore.

AI spending is less than 15% complete in Dan Ives' view, with NVIDIA, Palantir, Meta and the neoclouds anchoring a bull run he sees lasting 2 to 3 more years.

AMD stock still looks expensive heading into its critical third-quarter earnings report.

Cathie Wood has provocative ideas and has delivered some strong returns, but her firm's flagship ETF could be a risky bet for the future.

Which chipmaker has the most riding on the ChatGPT maker's ability to pay?

Ocular Therapeutix (NASDAQ:OCUL) is preparing a fourth-quarter new drug application submission for AXPAXLI, its investigational maintenance treatment for wet age-related macular degeneration, following discussions with the U.S. Food and Drug Administration, President and Chief Executive Officer Prav

SOXL fell about 20% in a month, but short interest dropped 65.6% and institutions like JPMorgan expanded holdings, signaling bets on a semiconductor sector rebound.

Check out the companies making headlines yesterday: Datadog (NASDAQ:DDOG): Cloud monitoring platform Datadog (NASDAQ:DDOG) rose by 4.7% on Monday after easin...

SOXX surged 79.5% over one year but carries higher volatility and fees. XLK offers lower costs, steadier returns, and better income for diversified tech exposure.

Anthropic could go public as soon as November.

One foundational artificial intelligence (AI) stock could surpass a $3 trillion valuation if Wall Street’s loftiest price target proves accurate.

AI hardware stocks slid on demand fears, but Chaikin Analytics says sticky-demand software and chip names like Palantir, ServiceNow, CrowdStrike and AMD could lead a post-midterm rally.